Elaboration of a nomogram to predict non sentinel node status in breast cancer patients with positive sentinel node, intra-operatively assessed with one step nucleic acid amplifica...

por Di Filippo, F., Giannarelli, D., Bouteille, C., Bernet, L., Cano, R., Cunnick, G., Sapino, A.
Publicado 2015

Potentiation of humoral response to the BNT162b2 vaccine after the third dose in patients with solid cancer

por Di Noia, V., Pimpinelli, F., Renna, D., Maccallini, M.T., Gariazzo, L., Riva, F., Sperandio, E., Giannarelli, D., Cognetti, F.
Publicado 2022

Flow cytometric analysis of ploidy in colorectal cancer: a multicentric experience.

por Silvestrini, R., D'Agnano, I., Faranda, A., Costa, A., Zupi, G., Cosimelli, M., Quagliuolo, V., Giannarelli, D., Gennari, L., Cavaliere, R.
Publicado 1993

Social distress among medical oncologists and other healthcare professionals during the first wave of COVID-19 pandemic in Italy

por Berardi, R., Torniai, M., Cona, M.S., Cecere, F.L., Chiari, R., Guarneri, V., La Verde, N., Locati, L., Lorusso, D., Martinelli, E., Giannarelli, D., Garassino, M.C.
Publicado 2021

Activity and Safety of Bevacizumab Plus Fotemustine for Recurrent Malignant Gliomas

por Vaccaro, V., Fabi, A., Vidiri, A., Giannarelli, D., Metro, G., Telera, S., Vari, S., Piludu, F., Carosi, M. A., Villani, V., Cognetti, F., Pompili, A., Marucci, L., Carapella, C. M., Pace, A.
Publicado 2014

Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients

por Ferrucci, P F, Gandini, S, Battaglia, A, Alfieri, S, Di Giacomo, A M, Giannarelli, D, Cappellini, G C Antonini, De Galitiis, F, Marchetti, P, Amato, G, Lazzeri, A, Pala, L, Cocorocchio, E, Martinoli, C
Publicado 2015

Effects of active cancer treatment on safety and immunogenicity of COVID-19 mRNA-BNT162b2 vaccine: preliminary results from the prospective observational Vax-On study

por Nelli, F., Fabbri, A., Onorato, A., Giannarelli, D., Silvestri, M.A., Giron Berrios, J.R., Virtuoso, A., Marrucci, E., Signorelli, C., Chilelli, M.G., Primi, F., Schirripa, M., Mazzotta, M., Ruggeri, E.M.
Publicado 2022

Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trials

por Ferretti, G, Bria, E, Giannarelli, D, Felici, A, Papaldo, P, Fabi, A, Di Cosimo, S, Ruggeri, E M, Milella, M, Ciccarese, M, Cecere, F L, Gelibter, A, Nuzzo, C, Cognetti, F, Terzoli, E, Carlini, P
Publicado 2006

Six month immunogenicity of COVID-19 mRNA-BNT162b2 vaccine in actively treated cancer patients: updated results of the Vax-On study

por Nelli, F., Fabbri, A., Onorato, A., Giannarelli, D., Silvestri, M.A., Pessina, G., Giron Berrios, J.R., Virtuoso, A., Marrucci, E., Schirripa, M., Mazzotta, M., Panichi, V., Cercola, P., Signorelli, C., Chilelli, M.G., Primi, F., Ruggeri, E.M.
Publicado 2022

Antineoplastic treatment class modulates COVID-19 mRNA-BNT162b2 vaccine immunogenicity in cancer patients: a secondary analysis of the prospective Vax-On study

por Ruggeri, E.M., Nelli, F., Fabbri, A., Onorato, A., Giannarelli, D., Giron Berrios, J.R., Virtuoso, A., Marrucci, E., Mazzotta, M., Schirripa, M., Panichi, V., Pessina, G., Signorelli, C., Chilelli, M.G., Primi, F., Natoni, F., Fazio, S., Silvestri, M.A.
Publicado 2021

Immunogenicity and early clinical outcome after two or three doses of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: results from the prospective observation...

por Nelli, F., Giannarelli, D., Fabbri, A., Silvestri, M.A., Berrios, J. R. Giron, Virtuoso, A., Marrucci, E., Schirripa, M., Mazzotta, M., Onorato, A., Panichi, V., Topini, G., Pessina, G., Natoni, F., Signorelli, C., Chilelli, M.G., Primi, F., Ruggeri, E.M.
Publicado 2022

LBA82 Influenza-like illness and SARS-Cov-2 in the multicenter, prospective, observational INVIDIa-2 study (INfluenza Vaccine Indication During therapy with Immune checkpoint inhib...

por Bersanelli, M., Giannarelli, D., Verzoni, E., Buti, S., De Giorgi, U., Clemente, A., Filetti, M., Di Napoli, M., Calvetti, L., Ermacora, P., Catino, A.M., Guaitoli, G., Bonomo, P., Mazzoni, F., Veccia, A., Grosso, F., Maruzzo, M., Rossi, E., Grossi, F., Procopio, G.
Publicado 2020

Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access Program

por Rebuzzi, S.E., Signori, A., Buti, S., Banna, G.L., Murianni, V., Damassi, A., Maruzzo, M., Giannarelli, D., Tortora, G., Galli, L., Rizzo, M., De Giorgi, U., Antonuzzo, L., Bracarda, S., Cartenì, G., Atzori, F., Tamberi, S., Procopio, G., Fratino, L., Lo Re, G., Santoni, M., Baldessari, C., Astone, A., Calabrò, F., Brunelli, M., Porta, C., Rescigno, P., Basso, U., Fornarini, G.
Publicado 2022